List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 232 studies with search of: hip replacement
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery
Conditions: Thrombosis;   Hip Replacement
Intervention: Drug: DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor
2 Completed Postoperative Analgesia After Total Hip Replacement
Condition: Total Hip Replacement
Interventions: Drug: Intrathecal morphine at surgery, 0.1mg and placebo;   Drug: Patient Controlled Analgesia with iv morphine and placebo;   Drug: intrathecal morphine AND patient controlled analgesia with iv morphine
3 Recruiting RCT Comparing Ion Levels and Clinical Outcomes of A-Class BFH to Metal on Polyethylene Total Hip Replacement
Condition: Hip Replacement
Interventions: Device: A Class BFH;   Device: Metal on Polyethylene
4 Not yet recruiting Efficacy of Preoperative Education and Mini-Invasive Surgery for Total Hip Replacement
Condition: Osteoarthritis of the Hip
Intervention: Procedure: -preoperative education and total hip replacement
5 Completed Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty
Condition: Hip Replacement Arthroplasty
Interventions: Drug: Hydroxyethyl Starch;   Drug: Ringer's lactate
6 Recruiting Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement
Condition: Arthritis
Intervention: Procedure: Total hip replacement
7 Active, not recruiting Metal Ion Release From an FDA-Approved Metal-on-Metal Total Hip Replacement Implant
Condition: Non-inflammatory Degenerative Joint Disease
Intervention: Procedure: Total Hip Replacement
8 Completed Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement
Condition: Hip Replacement Surgery
Intervention: Drug: Fibrin Sealant Vapor-Heated Solvent/Detergent-treated
9 Recruiting Ceramic on Metal Total Hip Replacement System Multi-Center,Investigational Device Exemption Clinical Trial
Condition: Total Hip Replacement
Intervention: Device: Ceramic on metal prosthesis
10 Completed Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery
Condition: Venous Thromboembolism
Interventions: Drug: AVE5026;   Drug: Enoxaparin
11 Active, not recruiting Safety and Effectiveness Study of the Reflection Ceramic Acetabular System
Condition: Osteoarthritis
Interventions: Device: Reflection Ceramic-Ceramic Total Hip Replacement;   Device: Reflection FSO V Total Hip Replacement
12 Completed Primary Ceramic-on-Ceramic Total Hip Replacement Versus Metal-on-Metal Hip Resurfacing in Young Active Patients
Condition: Indications for a Total Hip Prosthesis
Intervention: Device: ceramic-on-ceramic total hip replacement versus metal-on-metal hip resurfacing
13 Completed Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)
Condition: Arthroplasty, Replacement, Hip
Intervention: Drug: Enoxaparin sodium
14 Completed Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
Conditions: Arthroplasty, Replacement, Hip;   Venous Thromboembolism
Intervention: Drug: Fondaparinux
15 Active, not recruiting A Randomised Single Centre Study to Compare the Long-Term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement
Conditions: Osteoarthritis;   Post-Traumatic Arthritis;   Collagen Disorder;   Avascular Necrosis;   Traumatic Femoral Fractures;   Nonunion of Femoral Fractures;   Congenital Hip Dysplasia;   Slipped Capital Femoral Epiphysis
Interventions: Device: Ultima LX Collared Stem - Blasted Finished;   Device: Ultima LX Collared Stem - Polished Finished;   Device: Ultima LX Collarless Stem - Blasted Finished;   Device: Ultima LX Collarless Stem - Polished finished
16 Completed A Targeted Strengthening Program Following Total Hip Replacement.
Condition: Total Hip Joint Replacement
Intervention: Behavioral: Strength training program
17 Completed Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement
Condition: Blood Loss, Surgical
Interventions: Drug: Trasylol (Aprotinin, BAYA0128);   Drug: Placebo
18 Completed Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
Condition: Thromboembolism
Intervention: Drug: YM150
19 Completed Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain
Condition: Pain, Postoperative
Intervention: Drug: Paracetamol (acetaminophen)
20 Recruiting A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Conditions: Venous Thromboembolism;   Arthroplasty, Replacement, Hip
Interventions: Drug: YM150;   Drug: enoxaparin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services